In June 2023, the Centers for Disease Control and Prevention (CDC) issued a health advisory reporting two cases of malaria in the United States that were not related to travel.1 These were the first instances of locally acquired malaria in more than 20 years.2 In October 2023, the CDC reported a total of nine non-travel cases of malaria in the United States.2
To gain a better understanding of the trends in mosquito-borne illnesses, we analyzed the incidence of new diagnoses of malaria and dengue fever in the United States between January 2015 and December 2023. Our findings revealed that rates of new malaria diagnoses were around 29 per million patients in 2015 and 2016 and trended down to the lowest rate of 10.0 cases per million patients occurring in 2020. This decrease might be correlated with reduced travel during the COVID-19 pandemic. However, the rate has since increased to 19.1 per million in 2022 and 23.0 per million patients in 2023, as shown in Figure 1. The rates of new dengue fever diagnoses were even less common, with rates of fewer than eight cases per million patients for all years studied, though the highest rate was observed in 2023.
While overall rates of malaria and dengue fever remain low, the proportion of cases that result in a hospital admission has been increasing. For malaria, the pre-pandemic hospitalization rate was trending up, from 12.2% in 2015 to 25.2% in 2019, dropped down to 23.7% in 2020, and has since trended upward to 32.9% in 2023. Dengue fever has followed a similar trend, as shown in Figure 2.
Original Publication Date: December 6, 2023
Last Updated: February 15, 2024